Rationale and Design of a Randomized, Double-Blind, Parallel-Group Study of Terutroban 30 mg/day versus Aspirin 100 mg/day in Stroke Patients: The Prevention of Cerebrovascular and Cardiovascular Events of Ischemic Origin with Terutroban in Patients with a History of Ischemic Stroke or Transient Ischemic Attack (PERFORM) Study

✍ Scribed by Bousser, M.G.; Amarenco, P.; Chamorro, A.; Fisher, M.; Ford, I.; Fox, K.; Hennerici, M.G.; Mattle, H.P.; Rothwell, P.M.

• Book ID: 119985092
• Publisher: S. Karger AG
• Year: 2009
• Tongue: English
• Weight: 215 KB
• Volume: 27
• Category: Article
• ISSN: 1015-9770
• DOI: 10.1159/000212671